Spots Global Cancer Trial Database for stage iiia esophageal adenocarcinoma
Every month we try and update this database with for stage iiia esophageal adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery | NCT02234180 | Adenocarcinoma ... Stage IIB Esoph... Stage IIIA Esop... Stage IIIB Esop... Stage IIIC Esop... | Placebo Regorafenib | 18 Years - | Academic and Community Cancer Research United | |
Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery | NCT02234180 | Adenocarcinoma ... Stage IIB Esoph... Stage IIIA Esop... Stage IIIB Esop... Stage IIIC Esop... | Placebo Regorafenib | 18 Years - | Academic and Community Cancer Research United | |
Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy | NCT02392377 | Stage IB Esopha... Stage IIA Esoph... Stage IIB Esoph... Stage IIIA Esop... Stage IIIB Esop... Stage IIIC Esop... | Paclitaxel Carboplatin Oxaliplatin Leucovorin Calc... Fluorouracil Radiation Thera... Therapeutic Con... Laboratory Biom... | 18 Years - | Case Comprehensive Cancer Center |